Home » Topics » Briefs » Other news to note

Other news to note
RSS

Veles Pharma prepares innovative drugs for launch

April 13, 2012

Amgen announces new acquisition agreement

April 11, 2012

Spectrum Pharmaceuticals announces acquisition

April 10, 2012

Xencor receives milestone payment from Boehringer Ingelheim

April 5, 2012

Amgen and AstraZeneca to jointly develop inflammation portfolio candidates

April 4, 2012

Forest Laboratories acquires intellectual property from Janssen

April 4, 2012

Novartis Nanobody candidate clear to enter phase I trial

April 3, 2012

Actelion focuses on follow-up prostanoid DP2 receptor antagonist

April 3, 2012

Phase I trials of e-Therapeutics anticancer drug clear to proceed

March 30, 2012

Depomed receives remaining license fee payment in Acuform collaboration

March 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...